{"transactions":[{"id":790371,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2026-05-06T20:15:11.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and non-statutory stock options (\"Options\") upon the conclusion of the Issuer's 2026 annual meeting of stockholders. 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a \"change in control\" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such \"change in control,\" death or disability."}],"balance_after":10000,"derivative":{"exercise_price":22.99,"exercise_date":"2027-05-04","expiration_date":"2036-05-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-209006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000119312526209006/ownership.xml","form_type":"4"}},{"id":790370,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T20:15:11.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":9786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and non-statutory stock options (\"Options\") upon the conclusion of the Issuer's 2026 annual meeting of stockholders. 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a \"change in control\" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such \"change in control,\" death or disability."}],"balance_after":140492,"source":{"system":"sec-edgar","filing":"0001193125-26-209006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000119312526209006/ownership.xml","form_type":"4"}},{"id":849499,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:14:59.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":25640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date."}],"balance_after":25640,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":25640},"source":{"system":"sec-edgar","filing":"0001104659-26-026581","document":"tm268588-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026581/tm268588-2_4seq1.xml","form_type":"4"}},{"id":1139437,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2025-05-22T01:34:58.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2025 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":18.63,"exercise_date":"2026-05-19","expiration_date":"2035-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-25-051747","document":"tm2515701-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465925051747/tm2515701-4_4seq1.xml","form_type":"4"}},{"id":1139436,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T01:34:58.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":12077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2025 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":130706,"source":{"system":"sec-edgar","filing":"0001104659-25-051747","document":"tm2515701-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465925051747/tm2515701-4_4seq1.xml","form_type":"4"}},{"id":1279283,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:21:40.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest (i) 50% on February 5, 2026 and (ii) 50% on February 5, 2027, in each case subject to continuous service through such vesting date."}],"balance_after":54343,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-25-010567","document":"tm255864-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010567/tm255864-8_4seq1.xml","form_type":"4"}},{"id":1473733,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2024-06-20T20:58:14.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2024 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":16.16,"exercise_date":"2025-06-17","expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-073449","document":"tm2417570-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924073449/tm2417570-4_4seq1.xml","form_type":"4"}},{"id":1473732,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:58:14.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":13923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2024 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":118629,"source":{"system":"sec-edgar","filing":"0001104659-24-073449","document":"tm2417570-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465924073449/tm2417570-4_4seq1.xml","form_type":"4"}},{"id":1573482,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:02:22.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":54343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date."}],"balance_after":94009,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":54343},"source":{"system":"sec-edgar","filing":"0001104659-24-035727","document":"tm249071-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035727/tm249071-6_4seq1.xml","form_type":"4"}},{"id":1573481,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:02:22.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":39666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024."}],"balance_after":39666,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":39666},"source":{"system":"sec-edgar","filing":"0001104659-24-035727","document":"tm249071-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035727/tm249071-6_4seq1.xml","form_type":"4"}},{"id":1700437,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-27T02:55:39.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":10461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests immediately prior to the Company's 2024 annual shareholders meeting."}],"balance_after":10461,"derivative":{"exercise_price":2.39,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":10461},"source":{"system":"sec-edgar","filing":"0001104659-23-129371","document":"tm2333426-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129371/tm2333426-4_4seq1.xml","form_type":"4"}},{"id":1880195,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2023-05-24T21:54:29.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":13.64,"exercise_date":"2024-05-22","expiration_date":"2033-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-064213","document":"tm2316873-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064213/tm2316873-4_4seq1.xml","form_type":"4"}},{"id":1880194,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:54:29.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":16495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":104706,"source":{"system":"sec-edgar","filing":"0001104659-23-064213","document":"tm2316873-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064213/tm2316873-4_4seq1.xml","form_type":"4"}},{"id":2289873,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2022-04-27T22:48:37.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":17.79,"exercise_date":"2023-04-25","expiration_date":"2032-04-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-22-009042","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009042/doc1.xml","form_type":"4"}},{"id":2289872,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T22:48:37.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":12647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":88211,"source":{"system":"sec-edgar","filing":"0001567619-22-009042","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009042/doc1.xml","form_type":"4"}},{"id":2296620,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T19:54:50.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":33000,"derivative":{"exercise_price":5.11,"expiration_date":"2032-04-13","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001104659-22-046453","document":"tm2212851-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465922046453/tm2212851-7_4seq1.xml","form_type":"4"}},{"id":2676437,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T20:26:39.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":28000,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001104659-21-078789","document":"tm2119245-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465921078789/tm2119245-5_4seq1.xml","form_type":"4"}},{"id":2703788,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T00:14:08.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":17482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") upon the conclusion of the Issuer's 2021 annual meeting of stockholders. 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":75564,"source":{"system":"sec-edgar","filing":"0001567619-21-010827","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761921010827/doc1.xml","form_type":"4"}},{"id":2952417,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:07:53.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":3.15,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001104659-20-133637","document":"tm2038059-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920133637/tm2038059-5_4seq1.xml","form_type":"4"}},{"id":3168565,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-28T20:09:21.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":16917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":58082,"source":{"system":"sec-edgar","filing":"0001567619-20-008542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761920008542/doc1.xml","form_type":"4"}},{"id":3271842,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T23:04:14.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":27383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant."}],"balance_after":27383,"derivative":{"exercise_price":4.17,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":27383},"source":{"system":"sec-edgar","filing":"0001104659-20-022097","document":"tm208184-3_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465920022097/tm208184-3_form4.xml","form_type":"4"}},{"id":3319062,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:30:46.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":34.81,"underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0000950142-20-000048","document":"es2000133_4-schlesinger.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000048/es2000133_4-schlesinger.xml","form_type":"4"}},{"id":3319061,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:30:46.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":33.86,"underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0000950142-20-000048","document":"es2000133_4-schlesinger.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000048/es2000133_4-schlesinger.xml","form_type":"4"}},{"id":3319060,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-06T13:30:46.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":26383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option (each an \"Option\") that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser, whether vested or unvested, became fully vested and was canceled as of immediately prior to, and contingent upon, the effective time of the Merger, in exchange for the right to receive an amount in cash equal to the product of (x) the excess (if any) of the Offer Price over the per share exercise price payable in respect of each Share issuable under such Option, multiplied by (y) the number of Shares issuable under such Option."}],"balance_after":0,"derivative":{"exercise_price":29.83,"underlying":"Common Stock","underlying_shares":26383},"source":{"system":"sec-edgar","filing":"0000950142-20-000048","document":"es2000133_4-schlesinger.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000048/es2000133_4-schlesinger.xml","form_type":"4"}},{"id":3319059,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T13:30:46.000Z","date":"2020-01-06","kind":"disposition_to_issuer","acquired":false,"shares":7429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of November 23, 2019 (the \"Merger Agreement\"), by and among the Company, Novartis AG (\"Parent\") and Medusa Merger Corporation (\"Purchaser\"), on January 6, 2020, Purchaser was merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as an indirect wholly-owned subsidiary of Parent. Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each a \"Share\") was converted into the right to receive $85.00 per Share, net to the seller in cash (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Shares reported includes 3,663 unvested restricted Shares (each a \"Restricted Share\"). Each Restricted Share that was outstanding immediately prior to the consummation of the tender offer by Parent and Purchaser automatically became fully vested as of immediately prior to, and contingent upon, the effective time of the Merger and was treated in the same manner as an outstanding Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-20-000048","document":"es2000133_4-schlesinger.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000095014220000048/es2000133_4-schlesinger.xml","form_type":"4"}},{"id":3505104,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2019-06-03T17:11:10.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":8410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":8410,"derivative":{"exercise_price":34.81,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":8410},"source":{"system":"sec-edgar","filing":"0001179110-19-007026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007026/edgar.xml","form_type":"4"}},{"id":3505103,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T17:11:10.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":3663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 30, 2020 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":7429,"source":{"system":"sec-edgar","filing":"0001179110-19-007026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911019007026/edgar.xml","form_type":"4"}},{"id":3512267,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-25T01:58:00.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":16399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":41165,"source":{"system":"sec-edgar","filing":"0001104659-19-031861","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465919031861/a4.xml","form_type":"4"}},{"id":3908853,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right-to-buy)","published_at":"2018-06-04T16:54:51.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":9141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in one installment on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":9141,"derivative":{"exercise_price":33.86,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":9141},"source":{"system":"sec-edgar","filing":"0001179110-18-007957","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007957/edgar.xml","form_type":"4"}},{"id":3908852,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-04T16:54:51.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":3766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests on May 31, 2019 and was made as part of and pursuant to the Issuer's director compensation program."}],"balance_after":3766,"source":{"system":"sec-edgar","filing":"0001179110-18-007957","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018007957/edgar.xml","form_type":"4"}},{"id":3956393,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-26T20:10:38.000Z","date":"2018-04-24","kind":"grant","acquired":true,"shares":14249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":24766,"source":{"system":"sec-edgar","filing":"0001179110-18-005885","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018005885/edgar.xml","form_type":"4"}},{"id":4034460,"issuer":{"id":152552,"kind":"organization","name":"MEDICINES CO /DE","symbol":"MDCO"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Call Option (right-to-buy)","published_at":"2018-02-26T21:46:35.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":26383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in one installment on February 22, 2021 and is made part of and pursuant to Issuer's director compensation package."}],"balance_after":26383,"derivative":{"exercise_price":29.83,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":26383},"source":{"system":"sec-edgar","filing":"0001179110-18-002926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113481/000117911018002926/edgar.xml","form_type":"4"}},{"id":4059928,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-14T22:39:53.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":10517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10517,"source":{"system":"sec-edgar","filing":"0001179110-18-002082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000117911018002082/edgar.xml","form_type":"4"}},{"id":4443862,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":23.82,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443861,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":4.91,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443860,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":6.45,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443859,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":7.39,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443858,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the tender offer by Takeda and Purchaser to acquire all the outstanding Shares for $24.00 in cash (the \"Offer\"), whether vested or unvested, automatically became fully vested and was canceled as of immediately prior to, and contingent upon, the consummation of the Offer in exchange for the right to receive a lump-sum cash payment in the amount of the Option Consideration, if any, less any required withholding taxes, with respect to such Option. \"Option Consideration\" means, with respect to any Option, an amount equal to the product of (i) the number of Shares issuable under such Option multiplied by (ii) the excess of (x) $24.00 over (y) the exercise price payable in respect of each Share issuable under such Option; provided, however, that the Option Consideration for each Option with an exercise price equal to or greater than $24.00 shall be $0."}],"balance_after":0,"derivative":{"exercise_price":20.98,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443857,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-16","kind":"disposition_to_issuer","acquired":false,"shares":55508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 8, 2017 (the \"Merger Agreement\"), between the Company, Takeda Pharmaceutical Company Limited (\"Takeda\") and Kiku Merger Co., Inc. (\"Purchaser\"), on February 16, 2017, Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive $24.00 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of Shares reported includes 5,508 unvested restricted Shares subject to a lapsing right of repurchase by the Company (each, a \"Restricted Share\") and 12,500 Shares underlying unvested restricted stock units (each, an \"RSU\"). By virtue of the Merger and without any required action on the part of the holder thereof, all vesting conditions and restrictions applicable to each Restricted Share lapsed and each Restricted Share was converted automatically into the right to receive $24.00 in cash. In addition, pursuant to the Merger Agreement, each RSU outstanding immediately prior to the consummation of the Merger automatically and without any required action on the part of its holder became fully vested and was converted immediately prior to, and contingent upon, the consummation of the Merger into a vested right to receive a lump-sum cash payment in an amount equal to $24.00 for each Share underlying the RSU, less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4443856,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-16T14:18:23.000Z","date":"2017-02-13","kind":"gift","acquired":false,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Spouse"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000884731-17-000060","document":"wf-form4_148727268924679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000060/wf-form4_148727268924679.xml","form_type":"4"}},{"id":4474262,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-01T16:56:29.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":25000,"price":23.82,"value":595500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options granted under our 2014 Long-Term Incentive Plan, as amended, and in accordance with our director compensation policy vest as to approximately one-fourth of the shares underlying the options on the last business day of each calendar quarter in 2017, subject to the terms of the award."}],"balance_after":25000,"derivative":{"exercise_price":23.82,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000884731-17-000013","document":"wf-form4_148598615810983.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000013/wf-form4_148598615810983.xml","form_type":"4"}},{"id":4474261,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-01T16:56:29.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") granted under our 2014  Long-Term Incentive Plan, as amended, and our director compensation policy.  The RSUs vest as to approximately one-fourth of the shares underlying the RSUs on the last business day of each calendar quarter in 2017, subject to the terms of the award."}],"balance_after":55508,"source":{"system":"sec-edgar","filing":"0000884731-17-000013","document":"wf-form4_148598615810983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000013/wf-form4_148598615810983.xml","form_type":"4"}},{"id":4474260,"issuer":{"id":134569,"kind":"organization","name":"ARIAD PHARMACEUTICALS INC"},"owners":[{"id":49455,"kind":"person","name":"Schlesinger Sarah J.","position":1,"cik":"0001579873","reported_name":"Schlesinger Sarah J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-01T16:56:29.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":5508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock granted in lieu of the annual cash retainer under our 2014 Long-Term Incentive Plan, as amended, and in accordance with our director compensation policy. The shares are subject to a lapsing right of repurchase by the Company that lapses as to approximately one-fourth of the shares on the last business day of each calendar quarter in 2017, subject to the terms of the award."}],"balance_after":43008,"source":{"system":"sec-edgar","filing":"0000884731-17-000013","document":"wf-form4_148598615810983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884731/000088473117000013/wf-form4_148598615810983.xml","form_type":"4"}}]}